PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15075667-12	2004	The recommended phase II dose of Doxil/docetaxel is 30/60 mg/m(2), q3 weeks, without G-CSF.	liposomal doxorubicin	33-38	colony stimulating factor 3	Homo sapiens	85-90	
11408509-10	2001	When used with G-CSF, it is Doxil 30 mg/m(2) and docetaxel 75 mg/m(2) every 4 weeks.	liposomal doxorubicin	28-33	colony stimulating factor 3	Homo sapiens	15-20	
11408509-4	2001	RESULTS: In conjunction with docetaxel 75 mg/m(2) every 4 weeks, the MTD of Doxil was 30 mg/m(2) and required granulocyte colony-stimulating factor (G-CSF) to prevent febrile neutropenia.	liposomal doxorubicin	76-81	colony stimulating factor 3	Homo sapiens	110-147	
11408509-4	2001	RESULTS: In conjunction with docetaxel 75 mg/m(2) every 4 weeks, the MTD of Doxil was 30 mg/m(2) and required granulocyte colony-stimulating factor (G-CSF) to prevent febrile neutropenia.	liposomal doxorubicin	76-81	colony stimulating factor 3	Homo sapiens	149-154